Skip to content

Kinecenter Gingelom

Active
Private limited companyfounded 2023active for 3 yearsSteenweg 210, 3890 Gingelom, BelgiumKBO/BCE: BE 0801.103.895
Summary

Kinecenter Gingelom has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €87,806 and a net result of €31,836. Equity has been growing by about 47% per year since 2023. Its solvency ranks better than 51% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 24-04-2023 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Establishment unit
2.344.514.051 3890 Gingelom, since 24-04-2023
Financial year end
31 December
Peppol
Reachable since 08-11-2025

Board and ownership

Board

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€59,587
▲ 46.5%
Turnover
≈ €130,000
estimated
Profit
€31,836
▲ 56.2%
Equity
€87,806
▲ 56.9%
Total assets
€136,672
▲ 55.1%
Filed on 08-07-2026, 23 days before the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 2.23, cash €64,626Figures for financial year 2025 (filed on 08-07-2026)Equity €87,806 (64.2% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 66% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 89=
equity 64.2% of total assets
Liquidity 87+1
short-term debt 30.2% · cash 47.3%
Profitability 98=
return on assets 23.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €8,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.23 (1.71 in 2024), above the usual 1.5. Short-term debt is 30.2% and cash 47.3% of total assets. 35.8% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 52% of them on solvency, 71% on liquidity, 58% on profitability and 82% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 2.23, cash €64,626
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 08-07-2026)
NBB · annual accounts
lowers risk · Equity €87,806 (64.2% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-07-2026, 23 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
23 days early
2024
22 days early
2023
21 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 3 accounts on average 22 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 9 July (3 of the last 3 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Recent changes

  1. · Gazette deed IncorporationAppointments: JACOBS Wouter (director) and LISMONT Evelien (director)
All 5 events

Comparable companies

These companies have the same main activity as Kinecenter Gingelom: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €118,000 and €149,000, founded in 2023.

CompanyTotal assetsGross margin
Kinecenter Gingelom Gingelom€136,672€59,587
MédiStreel Sainte-Ode€137,789€62,075
GYNEMAT Elsene€148,811€61,672
KDQ, Psychiater Leuven€131,090€54,344
PDCMED Héron€145,570€63,178
Gynécologie Philippe Simon Ukkel€117,676€62,790
CABINET MEDICAL MELISSA MORELLO Waterloo€132,129€58,940
Full comparison

Key facts about Kinecenter Gingelom

What is the company number of Kinecenter Gingelom?
The company number of Kinecenter Gingelom is 0801.103.895. The VAT number is the same number with BE in front: BE 0801.103.895.
Where is Kinecenter Gingelom based?
The registered office is at Steenweg 210, 3890 Gingelom.Company details
What does Kinecenter Gingelom do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Kinecenter Gingelom?
The legal form of Kinecenter Gingelom is Private limited company (BV).
When was Kinecenter Gingelom founded?
Kinecenter Gingelom was founded on 24-04-2023.
Is Kinecenter Gingelom still active?
Yes, Kinecenter Gingelom is an active enterprise in the KBO register.
What is the turnover of Kinecenter Gingelom?
The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €59,587 and 32 comparable companies (NACE 862). It probably lies between €100,000 and €170,000.Financials
Is Kinecenter Gingelom profitable?
In financial year 2025, Kinecenter Gingelom made a profit of €31,836.
Where can I find the annual accounts of Kinecenter Gingelom?
Kinecenter Gingelom filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Kinecenter Gingelom due?
Kinecenter Gingelom must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.